Skip to content

Clinical trials

Hemoglobinuria, Paroxysmal trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemoglobinuria, Paroxysmal Country / region: United Kingdom Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20091
20111
20121
20151
20162
20174
20183
20194
20205
20218
20222
20236
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Active, not recruiting7
Terminated7
Recruiting6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.17
Regeneron Pharmaceuticals7
BioCryst Pharmaceuticals4
Novartis Pharmaceuticals4
Apellis Pharmaceuticals, Inc.2
Hoffmann-La Roche2
Omeros Corporation2
ADARx Pharmaceuticals, Inc.1
Alnylam Pharmaceuticals1
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemoglobinuria, Paroxysmal45
Hemolysis5
Anemia3
Anemia, Hemolytic1
Atypical Hemolytic Uremic Syndrome1
Hemoglobinuria1
Myasthenia Gravis1
Neuromyelitis Optica1

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.